| Title : Clinical Utility of Amyloid Imaging in a Complex Case of Corticobasal Syndrome Presenting with Psychiatric Symptoms - Bensaidane_2014_J.Neurol.Disord_2_1 |
| Author(s) : Bensaidane MR , M-P F , Damasse G , Chenard M , Dionne C , Duclos M , Bouchard RW , Laforce R, Jr. |
| Ref : Journal of Neurology Disord , 2 :1 , 2014 |
| Abstract : |
| PubMedSearch : Bensaidane_2014_J.Neurol.Disord_2_1 |
| PubMedID: 26225355 |
| Title : Clinical Utility of Amyloid Imaging in a Complex Case of Corticobasal Syndrome Presenting with Psychiatric Symptoms - Bensaidane_2014_J.Neurol.Disord_2_1 |
| Author(s) : Bensaidane MR , M-P F , Damasse G , Chenard M , Dionne C , Duclos M , Bouchard RW , Laforce R, Jr. |
| Ref : Journal of Neurology Disord , 2 :1 , 2014 |
| Abstract : |
| PubMedSearch : Bensaidane_2014_J.Neurol.Disord_2_1 |
| PubMedID: 26225355 |
| Title : Clinical Utility of Amyloid Imaging in a Complex Case of Corticobasal Syndrome Presenting with Psychiatric Symptoms - Bensaidane_2014_J.Neurol.Disord_2_1 |
| Author(s) : Bensaidane MR , M-P F , Damasse G , Chenard M , Dionne C , Duclos M , Bouchard RW , Laforce R, Jr. |
| Ref : Journal of Neurology Disord , 2 :1 , 2014 |
| Abstract : |
| PubMedSearch : Bensaidane_2014_J.Neurol.Disord_2_1 |
| PubMedID: 26225355 |
| Title : Switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch - Sadowsky_2010_CNS.Neurosci.Ther_16_51 |
| Author(s) : Sadowsky C , Perez JA , Bouchard RW , Goodman I , Tekin S |
| Ref : CNS Neurosci Ther , 16 :51 , 2010 |
| Abstract : |
| PubMedSearch : Sadowsky_2010_CNS.Neurosci.Ther_16_51 |
| PubMedID: 20070789 |
| Title : The value of PET in mild cognitive impairment, typical and atypical\/unclear dementias: A retrospective memory clinic study - Laforce_2010_Am.J.Alzheimers.Dis.Other.Demen_25_324 |
| Author(s) : Laforce R, Jr. , Buteau JP , Paquet N , Verret L , Houde M , Bouchard RW |
| Ref : Am J Alzheimers Dis Other Demen , 25 :324 , 2010 |
| Abstract : |
| PubMedSearch : Laforce_2010_Am.J.Alzheimers.Dis.Other.Demen_25_324 |
| PubMedID: 20539026 |
| Title : Switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch - Sadowsky_2010_CNS.Neurosci.Ther_16_51 |
| Author(s) : Sadowsky C , Perez JA , Bouchard RW , Goodman I , Tekin S |
| Ref : CNS Neurosci Ther , 16 :51 , 2010 |
| Abstract : |
| PubMedSearch : Sadowsky_2010_CNS.Neurosci.Ther_16_51 |
| PubMedID: 20070789 |
| Title : The value of PET in mild cognitive impairment, typical and atypical\/unclear dementias: A retrospective memory clinic study - Laforce_2010_Am.J.Alzheimers.Dis.Other.Demen_25_324 |
| Author(s) : Laforce R, Jr. , Buteau JP , Paquet N , Verret L , Houde M , Bouchard RW |
| Ref : Am J Alzheimers Dis Other Demen , 25 :324 , 2010 |
| Abstract : |
| PubMedSearch : Laforce_2010_Am.J.Alzheimers.Dis.Other.Demen_25_324 |
| PubMedID: 20539026 |
| Title : The value of PET in mild cognitive impairment, typical and atypical\/unclear dementias: A retrospective memory clinic study - Laforce_2010_Am.J.Alzheimers.Dis.Other.Demen_25_324 |
| Author(s) : Laforce R, Jr. , Buteau JP , Paquet N , Verret L , Houde M , Bouchard RW |
| Ref : Am J Alzheimers Dis Other Demen , 25 :324 , 2010 |
| Abstract : |
| PubMedSearch : Laforce_2010_Am.J.Alzheimers.Dis.Other.Demen_25_324 |
| PubMedID: 20539026 |
| Title : Switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch - Sadowsky_2010_CNS.Neurosci.Ther_16_51 |
| Author(s) : Sadowsky C , Perez JA , Bouchard RW , Goodman I , Tekin S |
| Ref : CNS Neurosci Ther , 16 :51 , 2010 |
| Abstract : |
| PubMedSearch : Sadowsky_2010_CNS.Neurosci.Ther_16_51 |
| PubMedID: 20070789 |
| Title : Rivastigmine for Alzheimer's disease: Canadian interpretation of intermediate outcome measures and cost implications - Baladi_2000_Clin.Ther_22_1549 |
| Author(s) : Baladi JF , Bailey PA , Black S , Bouchard RW , Farcnik KD , Gauthier S , Kertesz A , Mohr E , Robillard A |
| Ref : Clin Ther , 22 :1549 , 2000 |
| Abstract : |
| PubMedSearch : Baladi_2000_Clin.Ther_22_1549 |
| PubMedID: 11192146 |
| Title : Rivastigmine for Alzheimer's disease: Canadian interpretation of intermediate outcome measures and cost implications - Baladi_2000_Clin.Ther_22_1549 |
| Author(s) : Baladi JF , Bailey PA , Black S , Bouchard RW , Farcnik KD , Gauthier S , Kertesz A , Mohr E , Robillard A |
| Ref : Clin Ther , 22 :1549 , 2000 |
| Abstract : |
| PubMedSearch : Baladi_2000_Clin.Ther_22_1549 |
| PubMedID: 11192146 |
| Title : Rivastigmine for Alzheimer's disease: Canadian interpretation of intermediate outcome measures and cost implications - Baladi_2000_Clin.Ther_22_1549 |
| Author(s) : Baladi JF , Bailey PA , Black S , Bouchard RW , Farcnik KD , Gauthier S , Kertesz A , Mohr E , Robillard A |
| Ref : Clin Ther , 22 :1549 , 2000 |
| Abstract : |
| PubMedSearch : Baladi_2000_Clin.Ther_22_1549 |
| PubMedID: 11192146 |